Search result for 'binge'

The Competition Commission of India (CCI) has cleared Tata Sons' acquisition of an additional 10% stake in Tata Play, bringing their total holding to 70%.

Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ADHD and Binge Eating Disorder in adults and children.

Tata Sons seeks CCI approval to acquire an additional 10% stake in Tata Play from Temasek Holdings, increasing its holding to 70%. The transaction is subject to CCI review.

Granules India's subsidiary receives USFDA approval for generic Lisdexamfetamine Dimesylate chewable tablets, a medication used to treat ADHD and binge eating disorder.

Tata Play's Binge platform expands to the Philippines, enabling Cignal TV's OTT aggregation platform, Cignal Super. Read about the partnership and its impact on the Philippine media landscape.

Despite tech, finance & media layoffs, the US job market remains strong with a low unemployment rate and consistent hiring across most industries. Learn why.